Clinical Trial Update: Evaluation of Low-dose Darunavir in a Switch Study [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a low-dose darunavir in a switch strategy for HIV infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Darunavir (darunavir)

Snippet

Sponsor: Willem Daniel Francois Venter | Conditions: HIV Infections | Phase 3 | Status: COMPLETED